Tag: Wegovy
-
Trump Admin Secures Deals to Lower GLP-1 Weight-Loss Drug Prices for Medicare and Private Patients
Overview: Aiming to curb rising costs for GLP-1 medications The Trump administration announced a landmark set of deals on Thursday with the pharmaceutical giants Novo Nordisk and Eli Lilly. The agreements are designed to reduce the out-of-pocket and list prices of GLP-1 drugs—medications increasingly prescribed for weight management and diabetes—especially for Medicare beneficiaries and other…
-
Unusual PET-CT Scan Patterns Linked to GLP-1 Weight-Loss Drugs
Overview: A new imaging wrinkle around popular GLP-1 medications GLP-1 receptor agonists, a class of drugs that has surged in popularity for weight loss and type 2 diabetes management, are facing fresh scrutiny. While these medications—sold under names like Ozempic, Wegovy, and Mounjaro—continue to help many shed pounds, doctors are now noting unfamiliar patterns on…
-
Unusual GLP-1 Drug Side Effect Could Skew PET-CT Scans, Study Warns
GLP-1 drugs are reshaping weight loss—and now imaging, too GLP-1 receptor agonists, best known by brand names like Ozempic, Wegovy, and Mounjaro, have surged in popularity for their powerful weight‑loss effects. But as their use has exploded—driven by a 700% rise in the United States from 2019 to 2023—so too have reports of unusual side…
-
GLP-1 Drugs May Skew PET-CT Scans: A Hidden Risk for Cancer Detection
Understanding the emerging imaging challenge with GLP-1 medications GLP-1 receptor agonists, including popular drugs like Ozempic, Wegovy, and Mounjaro, have transformed weight loss and diabetes management. Yet as usage surged—reported to have risen about 700% in the United States from 2019 to 2023—so have reports of unusual side effects. A less obvious consequence is their…
-
Wegovy and Ozempic: Could Semaglutide Help Alcohol Dependence?
The new front in addiction research: GLP-1 drugs and alcohol Semaglutide, the active ingredient in Wegovy (weight loss) and Ozempic (diabetes), is being explored beyond its approved uses. Anecdotal reports have noted that some people on these injections drink less alcohol, prompting researchers to study whether semaglutide could help those struggling with alcohol dependence. A…
-
Wegovy and Ozempic Could Help Alcohol Dependence: Early Findings
Background Wegovy and Ozempic are brand names for semaglutide, a GLP‑1 receptor agonist. While they are primarily used for obesity management and type 2 diabetes, researchers are beginning to explore whether these drugs might influence alcohol use disorders as well. In a small US study, investigators observed that some participants reduced their alcohol consumption while…
-
Semaglutide Could Aid Alcohol Dependence: Wegovy & Ozempic
New clues on semaglutide and alcohol dependence In recent years, semaglutide, the active ingredient in Wegovy and Ozempic, has drawn attention beyond weight loss and diabetes management. A small American study provides the first clinical hints that this GLP-1 receptor agonist could help people with alcohol use disorder by reducing the amount they drink during…
-
Medicamentos para emagrecer: a balança e a pele flácida
Introduction Weight loss medications like Wegovy and Mounjaro have gained popularity for their effectiveness in helping individuals shed pounds. However, as many have discovered, losing weight quickly can come with unexpected consequences—particularly the issue of loose skin. This article delves into the experiences of individuals like Emilly Murray, who after losing nearly 38 kilograms, faces…
-
Medicamentos para Emagrecer: Efeitos Surpreendentes na Pele Flácida
Introdução aos Medicamentos para Emagrecer Nos últimos anos, os medicamentos para emagrecer, como Wegovy e Mounjaro, têm ganhado popularidade no Reino Unido e em outras partes do mundo. Essas injeções atuam reduzindo o apetite e, em muitos casos, resultam em perda de peso significativa. No entanto, essa transformação nem sempre é acompanhada por uma resposta…